Delving into the Latest Updates on Nanjing Lanming Medical Technology Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Endocrinology and Metabolic Disease

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

DDC x DRDs	1

主要目的：采用单中心、随机、开放、自身交叉、单剂量、空腹三周期及餐后两周期给药设计，比较南京兰铭医疗科技有限公司委托精华制药集团股份有限公司生产的卡左双多巴缓释片（规格：每片含卡比多巴50 mg，左旋多巴200 mg）与MSD Pharma（Singapore） Pte. Ltd.持证的卡左双多巴缓释片（规格：每片含卡比多巴50 mg，左旋多巴200 mg；商品名：Sinemet®/息宁®）在健康人群中吸收程度和速度的差异。次要目的：评价空腹及餐后条件下，南京兰铭医疗科技有限公司委托精华制药集团股份有限公司生产的卡左双多巴缓释片（规格：每片含卡比多巴50 mg，左旋多巴200 mg）与MSD Pharma（Singapore） Pte. Ltd.持证的卡左双多巴缓释片（规格：每片含卡比多巴50 mg，左旋多巴200 mg；商品名：Sinemet®/息宁®）的安全性和耐受性。

[Translation]

Main purpose: Using a single-center, randomized, open, self-crossover, single-dose, three-cycle fasting and two-cycle postprandial dosing design, compare the differences in absorption degree and speed of the carbidopa sustained-release tablets (specifications: each tablet contains 50 mg carbidopa and 200 mg levodopa) produced by Nanjing Lanming Medical Technology Co., Ltd. and the carbidopa sustained-release tablets (specifications: each tablet contains 50 mg carbidopa and 200 mg levodopa; trade name: Sinemet®/Xining®) certified by MSD Pharma (Singapore) Pte. Ltd. in healthy people. Secondary objective: To evaluate the safety and tolerability of the carbidopa sustained-release tablets (specifications: each tablet contains 50 mg carbidopa and 200 mg levodopa) produced by Nanjing Lanming Medical Technology Co., Ltd. and the carbidopa sustained-release tablets (specifications: each tablet contains 50 mg carbidopa and 200 mg levodopa; trade name: Sinemet®) produced by MSD Pharma (Singapore) Pte. Ltd. under fasting and postprandial conditions.

Start Date-

Sponsor / Collaborator

Nanjing Lanming Medical Technology Co., Ltd.

100 Clinical Results associated with Nanjing Lanming Medical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Nanjing Lanming Medical Technology Co., Ltd.

Login to view more data

100 Deals associated with Nanjing Lanming Medical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Nanjing Lanming Medical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data